Clinical trials recruiting for Prostate Cancer (Diagnosis)
26
Recruiting trials
6
US states with sites
14
Countries
4%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2Phase 3 1Not applicable 21
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 177 Lutetium Prostate-Specific Membrane Antigen 617 | 1 |
| 68-Ga-NYM032 | 1 |
| Abiraterone 250 mg with food + prednisone | 1 |
| Actinium-225 Prostate-Specific Membrane Antigen 617 | 1 |
| PSMA PET/CT scan | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| New York | 2 |
| Connecticut | 1 |
| Illinois | 1 |
| Maryland | 1 |
| North Carolina | 1 |
Top cities
New York, New York 2Baltimore, Maryland 1Branford, Connecticut 1Brooklyn, New York 1Chicago, Illinois 1Durham, North Carolina 1Jamaica, New York 1Los Angeles, California 1San Francisco, California 1Staten Island, New York 1
Self-screener
Recruiting trials
- A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
- Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise
- Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
- Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
- Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
- Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
- Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
- Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
- High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
- INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
- Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
- Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
- Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
- Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
- PSMA PET for Surveillance After Focal Therapy
- Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
- Prehabilitation to Patients With Prostate Cancer
- Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
- Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
- TENS During Transperineal Prostate Biopsy
- The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
- Theranostic Applications of Radionuclides in Prostate Cancer
- Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
- Virtual Biopsy of Prostate Cancer Using PSMA PET and AI
- miRNA Panel for PCa Diagnosis
Related conditions
Trials recruiting for Prostate Cancer (Diagnosis) often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Prostate Cancer (Adenocarcinoma) 43Prostate Cancer (Post Prostatectomy) 14Prostate Cancer Patients Treated by Radiotherapy 7Radical Prostatectomy 5PSMA PET 4Prostate Specific Antigen 3Prostate Cancer Recurrent 11Prostate Cancer Metastatic Disease 9Prostate Cancer Metastatic 27
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Prostate Cancer (Diagnosis) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.